cover image - Uropathology, 2nd Edition
ISBN: 9780323653954
Copyright: 2022
Publication Date: 07-21-2022
Page Count: 688
Imprint: Elsevier
List Price: $262.99

Uropathology, 2nd Edition

by Ming Zhou, MD, PhD, George Netto, MD and Jonathan I Epstein

Hardcover

cover image - Uropathology, 2nd Edition
ISBN: 9780323653954
Copyright: 2022
Publication Date: 07-21-2022
Page Count: 688
Imprint: Elsevier
List Price: $262.99
In Stock
Technical Support
Contact your education consultant to learn more about adopting this product
    • Provides in-depth, bulleted outlines for each entity covering definition, anatomy, and pathology: histology, immunohistochemistry, and differential diagnosis.
    • Features 1,600 high-quality illustrations that include gross, radiographic imaging, microscopic, immunohistochemical, and special stains, providing a comprehensive visual summary of the typical features of each entity.
    • Includes expanded information on tumor staging expertly provided by Dr. Ming Zhou, primary author of the College of American Pathologists cancer protocols.
    • Reflects recent guidelines and protocols including:
      • Restructured tumor classification and new entities
      • New and modified grading systems for GU cancers
      • New and modified staging criteria for all GU cancers
      • New recommendations for reporting
      • New IHC and molecular markers for diagnosis and prognosis for GU cancers
    • Enhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices
  • A. NONNEOPLASTIC DISEASE OF THE PROSTATE
    1. Anatomy and Histology of the Prostate
    2. Seminal Vesicle/Ejaculatory Duct
    3. Cowper Gland
    4. Benign Prostatic Hyperplasia
    5. Acute Inflammation of the Prostate
    6. Chronic Inflammation of the Prostate
    7. Nonspecific Granulomatous Prostatitis
    8. Post-Biopsy Granuloma
    9. Prostatic Xanthoma
    10. Granulomatous Prostatitis of Infectious Etiology
    11. Simple Atrophy
    12. Cystic Atrophy
    13. Postatrophy Hyperplasia
    14. Partial Atrophy
    15. Adenosis
    16. Sclerosing Adenosis
    17. Clear Cell Cribriform Hyperplasia
    18. Hyperplasia of Mesonephric Remnants
    19. Basal Cell Hyperplasia
    20. Urothelial Metaplasia
    21. Squamous Metaplasia
    22. Mucin Cell Metaplasia
    23. Neuroendocrine Cells Involving the Prostate
    24. Verumontanum Mucosal Gland Hyperplasia
    25. Prostatic Infarct
    B. NEOPLASTIC DISEASE OF THE PROSTATE
    26. High-Grade Prostatic Intraepithelial Neoplasia (HGPIN)
    27. Intraductal Carcinoma of the Prostate
    28. Prostatic Carcinoma, Usual Variant
    29. Prostatic Carcinoma, Atrophic Variant
    30. Prostatic Carcinoma, Foamy Gland Variant
    31. Prostatic Carcinoma, Pseudohyperplastic Variant
    32. Prostatic Carcinoma, Mucinous Variant
    33. Prostatic Carcinoma, Microcystic Variant
    34. Prostatic Intraepithelial Neoplasia (PIN)-Like Adenocarcinoma
    35. Sarcomatoid Carcinoma
    36. Pleomorphic Giant Cell Carcinoma of the Prostate
    37. Lymphoepithelioma-Like Carcinoma of the Prostate
    38. Prostate Carcinoma with Squamous Differentiation
    39. Ductal Adenocarcinoma
    40. Prostatic Adenocarcinoma with Neuroendocrine Differentiation
    41. Well-Differentiated Neuroendocrine Tumor
    42. Small Cell Carcinoma, Prostate
    43. Prostatic Basal Cell Adenoma
    44. Basal Cell Carcinoma of the Prostate
    45. Squamous Neoplasms Including Squamous Cell and Adenosquamous Carcinoma
    46. Urothelial Carcinoma
    47. Prostatic Stromal Tumors of Uncertain Malignant Potential
    48. Prostatic Stromal Sarcoma
    49. Atypical Glands Suspicious for Prostatic Carcinoma
    50. High-Grade Prostatic Intraepithelial Neoplasia with Adjacent Atypical Glands
    51. Radiation-Induced Changes
    52. Hormonal Ablation-Induced Changes
    53. Cryoablation Therapy-Induced Changes
    54. Immunohistochemical Work-Up of Prostate Carcinoma
    55. Gleason Grading of Prostate Carcinoma
    56. Prostate Cancer Staging in Radical Prostatectomy
    57. Genetics and Genomics in Prostate Cancer
    58. Work-Up of “Vanishing” Cancer in Radical Prostatectomy
    59. Nonprostatic Adenocarcinoma Involving the Prostate
    C. SEMINAL VESICLES
    60. Anatomy and Histology of Seminal Vesicles
    61. Amyloidosis
    62. Seminal Vesicle Adenocarcinoma
    63. Mixed Epithelial and Stromal Tumor
    D. NONNEOPLASTIC DISEASE OF THE URINARY BLADDER
    64. Anatomy and Histology of the Urinary Bladder
    65. von Brunn Nests
    66. Cystitis Cystica et Glandularis
    67. Squamous Metaplasia
    68. Intestinal Metaplasia
    69. Nephrogenic Metaplasia/Adenoma
    70. Polypoid and Papillary Cystitis
    71. Follicular Cystitis
    72. Giant Cell Cystitis
    73. Interstitial Cystitis/Painful Bladder Syndrome
    74. Eosinophilic Cystitis
    75. Infectious Cystitis
    76. Malakoplakia
    77. Granulomatous Cystitis After BCG
    78. Radiation Cystitis
    79. Chemotherapy-Induced Cystitis
    80. Endometriosis of the Bladder
    81. Bladder Endocervicosis
    82. Bladder Exstrophy
    83. Urachal Anomaly
    84. Bladder Diverticulum
    85. Ectopic Prostate Tissue
    E. NEOPLASTIC DISEASE OF THE URINARY BLADDER
    86. Urothelial Proliferation of Uncertain Malignant Potential
    87. Reactive Urothelial Atypia
    88. Urothelial Atypia of Unknown Significance
    89. Urothelial Dysplasia
    90. Urothelial Carcinoma In Situ
    91. Urothelial Papilloma
    92. Inverted Papilloma
    93. Papillary Urothelial Neoplasm of Low Malignant Potential
    94. Low-Grade Papillary Urothelial Carcinoma
    95. High-Grade Papillary Urothelial Carcinoma
    96. Invasive Urothelial Carcinoma
    97. Urothelial Carcinoma with Inverted Growth Pattern
    98. Urothelial Carcinoma with Squamous Differentiation
    99. Urothelial Carcinoma with Villoglandular Differentiation
    100. Urothelial Carcinoma, Plasmacytoid Variant
    101. Urothelial Carcinoma, Nested Variant
    102. Urothelial Carcinoma, Micropapillary Variant
    103. Urothelial Carcinoma, Microcystic Variant
    104. Urothelial Carcinoma, Lymphoepithelioma- Like Carcinoma Variant
    105. Urothelial Carcinoma, Clear Cell (Glycogen-Rich) Variant
    106. Lipid-Rich Urothelial Carcinoma
    107. Urothelial Carcinoma, Giant Cell Variant
    108. Urothelial Carcinoma with Syncytiotrophoblastic Giant Cells
    109. Urothelial Carcinoma with Rhabdoid Differentiation
    110. Urothelial Carcinoma Similar to Giant Cell Tumor of Bone
    111. Undifferentiated Urothelial Carcinomas
    112. Small Cell Carcinoma of the Urinary Bladder
    113. Urothelial Carcinoma with Unusual Stromal Reactions
    114. Urothelial Carcinoma with Sarcomatoid Differentiation
    115. Villous Adenoma
    116. Adenocarcinoma
    117. Clear Cell Adenocarcinoma
    118. Urachal Adenocarcinoma
    119. Squamous Cell Carcinoma
    120. Paraganglioma
    121. Staging of Urothelial Carcinoma of the Urinary Bladder and Urethra
    122. Molecular Genomics of Bladder Cancer
    123. Secondary Spread of Prostate Carcinoma to the Bladder
    124. Secondary Adenocarcinoma Involving the Bladder, Other than Prostatic Carcinoma
    F. NONNEOPLASTIC DISEASE OF THE KIDNEY
    125. Anatomy of the Kidney
    126. Renal Dysplasia
    127. Localized Cystic Disease of the Kidney
    128. Autosomal Recessive Polycystic Kidney Disease
    129. Autosomal Dominant Polycystic Kidney Disease
    130. Medullary Sponge Kidney
    131. Acquired Cystic Renal Disease
    132. Simple Cortical Cyst
    133. Acute Pyelonephritis
    134. Chronic Nonobstructive Pyelonephritis
    135. Chronic Obstructive Pyelonephritis
    136. Xanthogranulomatous Pyelonephritis
    137. Renal Papillary Necrosis
    138. Benign Nephrosclerosis
    139. Malignant Nephrosclerosis
    140. Acute Kidney Injury (Acute Tubular Necrosis)
    141. Acute Interstitial Nephritis
    142. Infectious Interstitial Nephritis
    G. NEOPLASTIC DISEASE OF THE KIDNEY
    143. Papillary Adenoma
    144. Renal Oncocytoma
    145. Clear Cell Renal Cell Carcinoma
    146. Multilocular Cystic Renal Neoplasm of Low Malignant P
  • Ming Zhou, MD, PhD, Dr. Charles T. Ashworth Professor of Pathology, Director of Anatomic Pathology, UT Southwestern Medical Center, Dallax, Texas, George Netto, MD, Professor and Chair of Pathology, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama and Jonathan I Epstein, Reinhard Professor of Urologic Pathology, Director of Surgical Pathology, Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland